Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard ... ( 'United Kingdom Needs to Wake Up to ...)

Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection

Date:4/22/2008

'United Kingdom Needs to Wake Up to Threat of Bioterrorism,' Says UK Board

Member General Lord Guthrie

BOSTON, April 22 /PRNewswire/ -- BioDefense Corp., the only company in the world to develop and deploy technology that can neutralize and destroy a biohazardous substance while maintaining the integrity of the tainted materials, today announced it has partnered with General Lord Guthrie, former chief of the British Defense Staff, to establish new security markets for the BioDefense MailDefender(R) in the United Kingdom.

The BioDefense MailDefender system was developed to give organizations increased control over a potentially uncontrollable situation -- the risk of bio-contamination through the mail. This first-of-its kind system decontaminates mail at the point of entry, protecting employees from harm and organizations from the threats of an actual attack or a disruptive hoax.

The MailDefender(R) is currently deployed at the United Nations, U.S. Department of Justice, U.S. Department of Defense, Department of Alcohol, Tobacco and Firearms and several embassies worldwide.

The directors of BioDefense Corp. are hosting an event today to celebrate the partnership between the United States and the United Kingdom. General Lord Guthrie, member of the House of Lords and new member of the BioDefense advisory board, will speak at the company's new Boston world headquarters about the challenges of and solutions to biological threats.

Said BioDefense Executive Vice President Jonathan Morrone: "We are a global company helping countries and corporations worldwide keep their people safe from biological threats, whether the threats originate domestically or internationally. We believe our partnership with General Lord Guthrie and our two countries will further our nations' abilities to defend against bioterrorism, as well as the security hoaxes that often cripple productivity in government agencies and corporate ent
'/>"/>

19

GOOD

Page: 1 2 3
Related biology technology :

1. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
2. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
3. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
4. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
5. HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
6. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
7. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
8. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
9. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
10. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
11. BioMagnetics Diagnostics Corp. Rated Speculative Buy, Target Price $1.42 by Beacon Equity Research

Post Your Comments:

Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard ...( 'United Kingdom Needs to Wake Up to ...)